NYSE: EXPEagle Materials Inc Stock
$223.72+2.52 (+1.14%)
Updated Nov 28, 2025
EXP Price
$223.72
Fair Value Price
N/A
Market Cap
$7.17B
52 Week Low
$191.91
52 Week High
$309.23
P/E
16.39x
P/B
4.67x
P/S
3.27x
PEG
2.43x
Dividend Yield
0.45%
Revenue
$2.30B
Earnings
$446.80M
Gross Margin
29%
Operating Margin
26.49%
Profit Margin
19.4%
Debt to Equity
1.22
Operating Cash Flow
$524M
Beta
1.21
Next Earnings
N/A
Ex-Dividend
Dec 15, 2025
Next Dividend
Jan 12, 2026
EXP Overview
Eagle Materials Inc. manufacturers building materials. Offerings include cement, concrete, construction aggregate, gypsum, wallboard, paperboard, and sand. Eagle Materials was founded in 1963 and is based in Dallas, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine EXP's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Building Material
Industry Rating
D
EXP
Ranked#10 of 14
Ranked#10 of 14
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.79 | B | |
| $16.24 | B | |
| $121.57 | C |
Be the first to know about important EXP news, forecast changes, insider trades & much more!
EXP News
Overview
Due Diligence Score
–
Industry Average (34)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how EXP scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
EXP ($223.72) is trading above its intrinsic value of $116.53, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
EXP is good value based on its earnings relative to its share price (16.39x), compared to the US market average (45.69x)
P/E vs Market Valuation
EXP is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more EXP due diligence checks available for Premium users.
Valuation
EXP price to earnings (PE)
For valuing profitable companies with steady earnings
Company
16.39x
Industry
26.23x
Market
45.69x
EXP is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
EXP is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
EXP price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.67x
Industry
2.91x
EXP is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
EXP price to earnings growth (PEG)
For valuing profitable companies with growth potential
EXP is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
EXP's financial health
Profit margin
Revenue
$638.9M
Net Income
$137.4M
Profit Margin
21.5%
EXP's Earnings (EBIT) of $609.84M... subscribe to Premium to read more.
Interest Coverage Financials
EXP's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.4B
Liabilities
$1.9B
Debt to equity
1.22
EXP's short-term assets ($671.30M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EXP's long-term liabilities ($1.63B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EXP's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
EXP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$204.6M
Investing
-$108.5M
Financing
-$120.8M
EXP's operating cash flow ($523.88M)... subscribe to Premium to read more.
Debt Coverage Financials
EXP vs Building Material Stocks
Eagle Materials Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.